Writing for The Pharmaceutical Journal, Julia Robinson reports:
“The Department of Health and Social Care (DHSC) will not be taking forward recommendations to set up a helpline to support patients struggling with prescribed drug dependence, The Pharmaceutical Journal has learned.
This follows the failure of a spending review bid for the helpline submitted to HM Treasury in September 2021, meeting minutes released through a Freedom of Information (FoI) request have revealed.
In 2019, Public Health England (PHE) — which has now been replaced by the UK Health Security Agency and the Office for Health Improvement and Disparities — published an evidence review on the dependence and withdrawal associated with some prescribed medicines.
It included a recommendation that the DHSC should look at introducing a ‘time-limited national helpline and associated website’ to provide expert advice and support to patients.
The report said the service should provide patients with a combination of support and guidance in the form of drug information, advice on withdrawal and withdrawal symptoms, non-drug alternatives and details of local support services …”
You can read more from here.